Depression

What is Depression?

Depression is a common and serious mental health disorder that negatively affects how a person feels, thinks, and acts. It can lead to a variety of emotional and physical problems and can decrease a person’s ability to function at work and home.

Types of Depression

1. Major Depressive Disorder (MDD)

2. Persistent Depressive Disorder (Dysthymia)

3. Bipolar Disorder

4. Seasonal Affective Disorder (SAD)

5. Postpartum Depression

Symptoms of Depression

Symptoms can vary in severity and may include:

Causes and Risk Factors

Diagnosis

Treatment Options

Prevention Strategies

Complications of Depression


References & Research

Historical Background

Depression has been recognized since antiquity -- Hippocrates described "melancholia" around 400 BCE as a condition caused by an excess of black bile. The modern clinical understanding of depression began with Emil Kraepelin's classification of "manic-depressive insanity" in the late 19th century, and the term "major depressive disorder" was formalized in the DSM-III in 1980.

Key Research Papers

  1. Kessler RC, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
  2. Cipriani A, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366.
  3. Malhi GS, Mann JJ. Depression. The Lancet. 2018;392(10161):2299-2312.
  4. Belmaker RH, Agam G. Major depressive disorder. New England Journal of Medicine. 2008;358(1):55-68.
  5. Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry. 2006;163(11):1905-1917.
  6. Cuijpers P, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry. 2013;58(7):376-385.
  7. Wray NR, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics. 2018;50(5):668-681.
  8. Daly EJ, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression (SUSTAIN-1). JAMA Psychiatry. 2019;76(9):893-903.
  9. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16(9):606-613.
  10. Ferrari AJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Medicine. 2013;10(11):e1001547.
  11. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function. 2008;213(1-2):93-118.
  12. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. American Journal of Psychiatry. 2010;167(10 Suppl):1-152.

Back to Table of Contents


Connections

Explore related topics across MyHealthcare: